bispecific antibodies (Immetas)

N/A

Report date: 2025/01/26 17:39:30

Base Information

Drug Namebispecific antibodies (Immetas)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInflammationNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmetas Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesImmetas Therapeutics

Inactive CompaniesN/A

Active IndicationsInflammationNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A